G. Solbu
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 29
- Hematopoietic Stem Cell Transplantation 10
- Multiple Myeloma Research and Treatments 5
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 10
-
- Acute Lymphoblastic Leukemia research 27
- Oncology top 5%
- Neutropenia and Cancer Infections 7
-
- Childhood Cancer Survivors' Quality of Life 12
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Stefan SuciuR ZittounBob LöwenbergM. PeetermansPieter SonneveldH M LokhorstU. JehnJ. Abels
- Journals
- Blood (6 papers)Journal of Clinical Oncology (4 papers)British Journal of Haematology (3 papers)
- Partner nations
- NetherlandsBelgiumFrance
In The Last Decade
G. Solbu
51 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 81
- Hematology 1.3k
- Genetics 382
- Public Health, Environmental and Occupational Health 779
- Oncology 707
- Pediatrics, Perinatology and Child Health 349
Countries citing papers authored by G. Solbu
This map shows the geographic impact of G. Solbu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Solbu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Solbu more than expected).
Fields of papers citing papers by G. Solbu
This network shows the impact of papers produced by G. Solbu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Solbu. The network helps show where G. Solbu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. Solbu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 52 | |
| 2 | Flt3 and MLL internal tandem duplications and topoisomerase II breakages reflect a common category of genotoxic stress: An EORTC study | 2002 | 2 |
| 3 | Allogeneic vs autologous stem cell transplantation according to cytogenetic and FAB features in AML patients (pts) <=45 yrs old in CRI: Results of the EORTC-GIMEMA AML-10 trial | 2002 | 2 |
| 4 | 2001 | 66 | |
| 5 | The type of anthracycline administered during remission induction and consolidation therapy of AML has an impact on feasibility of subsequent autologous or allogeneic transplantation and induced marrow toxicity: preliminary results of the EORTC-Gimema AML-10 randomized trial. | 2000 | 5 |
| 6 | 1998 | 218 | |
| 7 | 1997 | 94 | |
| 8 | 1996 | 19 | |
| 9 | 1996 | 96 | |
| 10 | 1996 | 12 | |
| 11 | 1996 | 164 | |
| 12 | Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study | 1995 | 1 |
| 13 | 1994 | 53 | |
| 14 | 1994 | 1 | |
| 15 | 1993 | 51 | |
| 16 | 1990 | 27 | |
| 17 | 1989 | 302 | |
| 18 | 1988 | 19 | |
| 19 | 1986 | 1 | |
| 20 | 1984 | 47 |
About G. Solbu
G. Solbu is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 51 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (29 papers), Acute Lymphoblastic Leukemia research (27 papers), Childhood Cancer Survivors' Quality of Life (12 papers), Chronic Lymphocytic Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (10 papers), Lymphoma Diagnosis and Treatment (8 papers), Neutropenia and Cancer Infections (7 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (382 citations) and Public Health, Environmental and Occupational Health (779 citations). G. Solbu has collaborated with scholars based in Netherlands, Belgium and France. Frequent co-authors include Stefan Suciu, R Zittoun, Bob Löwenberg, M. Peetermans, Pieter Sonneveld, H M Lokhorst, U. Jehn, J. Abels, L Debusscher and C Cauchie. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.